Chatillon, France

Patricia Lepage

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Paris, FR (2021)
  • Chatillon, FR (2020 - 2022)

Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Patricia Lepage: Innovator in Cancer Treatment Innovations

Introduction

Patricia Lepage, an accomplished inventor based in Chatillon, France, has made significant contributions to the field of cancer treatment through her innovative research. With three patents to her name, Lepage's work focuses on the intricate relationship between microbiota and cancer therapies, aiming to improve patient outcomes.

Latest Patents

Patricia Lepage's latest patents include groundbreaking inventions related to microbiota composition and its implications for chemotherapy responsiveness. One notable invention provides methods for determining if a patient is likely to benefit from a cancer treatment by assessing gut dysbiosis and the representation of certain bacterial species. Additionally, she developed methods utilizing microbial modulators, including prebiotics, probiotics, or synbiotics, designed to enhance the efficacy of cancer treatments, particularly chemotherapy, for patients in need. Her patent also addresses novel techniques for preparing fecal microbiota samples from donor subjects, following a meticulous method that ensures sample integrity and storage efficiency.

Career Highlights

Throughout her career, Patricia Lepage has been associated with prominent research institutions, including the National Institute for Agricultural Research (Institut National de Recherche Pour L'agriculture, L'alimentation Et L'environnement) and Gustave Roussy Institute (Institut Gustave Roussy). Her work has been pivotal in advancing the understanding of the microbiome's role in cancer treatment, allowing doctors to tailor therapies based on patients' unique microbiota profiles.

Collaborations

Patricia has collaborated with esteemed colleagues in her field, including Laurence Zitvogel and Ivo Gomperts Boneca. These partnerships have fostered innovative approaches to enhancing cancer treatment methodologies and patient care. Their collective expertise continues to drive forward the potential for using microbiota in personalized medicine.

Conclusion

Patricia Lepage's innovations and dedication to improving cancer treatment through microbiota research represent a significant advancement in the medical field. Her patents not only highlight her inventiveness but also contribute to the ongoing quest for more effective cancer therapies. As research continues in this area, Lepage's work may pave the way for more personalized and effective treatment options for cancer patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…